Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus

Immunobiology

Volumn 218, Issue 4, 2013, Pages 620-627

  Shah, Dilip ^a,b   Sah, Sangita ^c   Wanchu, Ajay ^d   Wu, Mei X ^a,e   Bhatnagar, Archana ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PANJAB UNIVERSITY   (India)

^c JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Altered redox state; Apoptosis; CGlutathione; Systemic lupus erythematosus (SLE)

Indexed keywords

CASPASE 3; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THIOL;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LIPID PEROXIDATION; LYMPHOCYTE; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; APOPTOSIS; CASPASE 3; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX;

EID: 84875273494     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.030     Document Type: Article

References (46)

1. Al Arfaj A.S., Chowdhary A.R., Khalil N., Ali R. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Clin. Immunol. 2007, 124:83.
2. Amital H., Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. Systemic Lupus Erythematosus 2004, 3. Elsevier Publication, Amsterdam, The Netherlands. 4th ed. G. Lahita Robert (Ed.).
3. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 1985, 113:548.
4. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009, 390:191.
5. Ben Mansour R., Lassoued S., Elgaied A., Haddouk S., Marzouk S., Bahloul Z., Masmoudi H., Attia H., Aifa M.S., Fakhfakh F. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand. J. Rheumatol. 2010, 39:247.
6. Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963, 61:882.
7. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35:630.
8. Bortner C.D., Cidlowski J.A. Apoptotic volume decrease and the incredible shrinking cell. Cell Death Differ. 2002, 9:1307.
9. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302.
10. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48:749.
11. Franco R., Cidlowski J.A. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009, 16:1303.
12. Franco R., Panayiotidis M.I., Cidlowski J.A. Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation. J. Biol. Chem. 2007, 282:30452.
13. Gergely P., Grossman C., Niland B., Puskas F., Neupane H., Allam F., Banki K., Phillips P.E., Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46:175.
14. Gergely P., Niland B., Gonchoroff N., Pullmann R., Phillips P.E., Perl A. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol. 2002, 169:1092.
15. Green D.R. Overview: apoptotic signaling pathways in the immune system. Immunol. Rev. 2003, 193:5.
16. Grisham B.M. Regulation of T-cell apoptosis by reactive oxygen species. Free Radic. Biol. Med. 2004, 36:1296.
17. Hammond C.L., Madejczyk M.S., Ballatori N. Activation of plasma membrane reduced glutathione transport in death receptor apoptosis of HepG2 cells. Toxicol. Appl. Pharmacol. 2004, 195:12.
18. Hassan S.Z., Gheita T.A., Kenawy S.A., Fahim A.T., El-Sorougy I.M., Abdou M.S. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int. J. Rheum. Dis. 2011, 14:325.
19. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
20. Jin O., Sun L., Zhou K., Zhang X., Feng X., Mok M., Lau C. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin. Rheumatol. 2005, 24:107.
21. Kasahara Y., Iwai K., Yachie A., Ohta K., Konno A., Seki H., Miyawaki T., Taniguchi N. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997, 89:1748.
22. Kay H.D. A new procedure to overlay diluted blood on Ficoll-hypaque gradients. J. Immunol. Methods 1980, 39:81.
23. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189.
24. Kurien B.T., Scofield R.H. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci. 2003, 73:1655.
25. Kurien B.T., Scofield R.H. Lipid peroxidation in systemic lupus erythematosus. Indian J. Exp. Biol. 2006, 44:349.
26. Li L.H., Li W.X., Wu O., Zhang G.Q., Pan H.F., Li X.P., Xu J.H., Dai H., Ye D.Q. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis. Mol. Biol. Rep. 2009, 36:2047.
27. Li K.J., Wu C.H., Hsieh S.C., Lu M.C., Tsai C.Y., Yu C.L. Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus. Clin. Dev. Immunol. 2012, 548516.
28. Lohr G.W., Waller H.D. Glucose-6-phosphate dehydrogenase. Meth. Enzym. Anal. 1974, 2:636.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265.
30. Luck H. Catalase. Methods of Enzymatic Analysis 1971, vol. III:885. Academic press, New York, 279.
31. Mansour R.B., Lassoued S., Gargouri B., El Gaid A., Attia H., Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 2008, 37:103.
32. Morgan P.E., Sturgess A.D., Davies M.J. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic. Res. 2009, 43:117.
33. Munoz L.E., van Bavel C., Franz S., Berden J., Herrmann M., van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008, 17:371.
34. Ortona E., Margutti P., Matarrese P., Franconi F., Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun. Rev. 2008, 7:579.
35. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158.
36. Perricone C., De Carolis C., Perricone R. Glutathione: a key player in autoimmunity. Autoimmun. Rev. 2009, 8:697.
37. Sarkar M., Varshney R., Chopra M., Sekhri T., Adhikari J.S., Dwarakanath B.S. Flow-cytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patients with thyroid dysfunction. Cytometry B: Clin. Cytom. 2006, 70:20.
38. Sedlak J., Hanus L. Changes of glutathione and protein bound SH-groups concentration in rat adrenals under acute and repeated stress. Endocrinol. Exp. 1982, 16:103.
39. Shah D., Kiran R., Wanchu A., Bhatnagar A. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol. Lett. 2010, 129:7.
40. Shah D., Aggarwal A., Bhatnagar A., Kiran R., Wanchu A. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic. Res. 2011, 45:559.
41. Shah D., Wanchu A., Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 2011, 216:1010.
42. Turgay M., Durak I., Erten S., Ertugrul E., Devrim E., Avci A., Turgay F. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J. Rheumatol. 2007, 10:101.
43. Turi S., Nemeth I., Torkos A., Saghy L., Varga I., Matkovics B., Nagy J. Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic. Biol. Med. 1997, 22:161.
44. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44.
45. Xue C., Lan-Lan W., Bei C., Jie C., Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell. Immunol. 2006, 239:121.
46. Zhang Q., Ye D.Q., Chen G.P., Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin. Exp. Dermatol. 2010, 35:287.